Relates to the regulation of municipal shooting ranges
Requires cognitive impairment screening during Medicare AWV and IPPE to enable earlier diagnosis and care planning for beneficiaries and caregivers.
Requires cognitive impairment screening during Medicare AWV and IPPE to enable earlier diagnosis and care planning for beneficiaries and caregivers.
S. 1799 seeks to amend title XVIII of the Social Security Act to require cognitive impairment detection as part of the Medicare Annual Wellness Visit (AWV) and the Initial Preventive Physical Examination (IPPE). The bill is framed as a measure to improve early identification of Alzheimer’s disease and other dementias, enabling timely care planning, treatment options, and caregiver support.
Note: The specific screening tools, reporting requirements, or timelines for implementing the cognitive impairment detection are not detailed in the summary text provided. The emphasis is on integrating detection into the AWV and IPPE.
The bill contains extensive findings about Alzheimer’s disease and related dementias, including:
- Prevalence and growth: estimated 6.9 million Americans with Alzheimer’s now, projected to nearly 13.8 million by 2060; about 1 in 11 people age 65+ has Alzheimer’s.
- Disparities: older Black Americans (2x) and Latino Americans (1.5x) more likely to have Alzheimer’s than older White Americans; roughly two-thirds of affected individuals are women.
- Burden and mortality: Alzheimer’s is a leading cause of death among 65+; deaths from dementia have risen significantly in recent decades.
- Economic impact: enormous costs from unpaid caregiving (approx. $347 billion in 2023), direct costs of dementia care (about $360 billion in 2024), with projected costs approaching $1.1 trillion by 2050; Medicare/Medicaid are expected to cover a substantial share of these costs, with substantial out-of-pocket spending as well.
- Potential for risk reduction: modifiable factors (hypertension, inactivity, smoking, depression, diabetes, obesity, nutrition) could prevent or delay up to ~40% of dementia cases.
- Benefits of early diagnosis: enables early access to care planning, treatments, support services, and trial enrollment; reduces caregiver burden and its health consequences.
This summary reflects the introduced text and accompanying findings; further amendments or committee reports could refine provisions, tools, and implementation timelines.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.